Skip to main content
LIFECOME BIOCHEMISTRY CO., LTD. logo

LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings

Ticker · 002868 ISIN · CNE100002QH2 LEI · 65560089EP03NANEN790 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,742 across all filing types
Latest filing 2026-03-09 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002868

About LIFECOME BIOCHEMISTRY CO., LTD.

https://www.pclifecome.com

Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.

Recent filings

Filing Released Lang Actions
第五届董事会第三十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 33rd meeting of the 5th Board of Directors of the company, including approval of the 2025 annual general manager's report, board work report, financial statements, budget, remuneration plans, internal control reports, and other governance matters. It references multiple reports and documents that are disclosed elsewhere (e.g., on the cninfo website and Securities Daily), but the document itself is a formal board meeting resolution announcement. It includes voting results and mentions which items require shareholder approval. This type of document is characteristic of Board/Management Information filings, as it focuses on board meeting decisions and governance matters rather than the full annual report or financial statements themselves. The document length (5826 characters) and content confirm it is not a brief announcement or a full annual report but a board meeting resolution announcement. Therefore, the appropriate classification is MANG (Board/Management Information).
2026-03-09 Chinese
公司2026年度董事薪酬方案
Remuneration Information Classification · 95% confidence The document is titled '2026 年董事薪酬方案' which translates to '2026 Directors' Remuneration Plan' for the company. It details the principles, standards, and management of director compensation for the year 2026. It includes specific remuneration amounts, payment methods, and organizational management related to director pay. There is no indication of it being a full annual report, audit report, or other financial report. Instead, it is a detailed report on director compensation, which fits the definition of Remuneration Information (DEF 14A). The document length is short and focused solely on remuneration, confirming it is not a general report or announcement but a remuneration report.
2026-03-09 Chinese
公司2025年度审计委员会履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a report from the Audit Committee of the Board regarding the supervision of the external auditor's work for the fiscal year 2025. It details the appointment process of the auditor, the auditor's qualifications, the audit scope, and the committee's evaluation of the auditor's performance and independence. The document does not contain the full annual financial statements or the full annual report but focuses on the audit committee's oversight and the auditor's work. The document length is 1782 characters, which is relatively short and focused on audit supervision rather than the full annual report. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and related supervisory information, excluding the full Annual Report (10-K). FY 2025
2026-03-09 Chinese
2025年年度报告
Annual Report Classification · 100% confidence The document is titled "绿康生化股份有限公司2025 年年度报告全文" which translates to "Lifecare Biochemistry Co., Ltd. 2025 Annual Report Full Text." It contains detailed sections typical of an annual report, including company overview, financial data, management discussion and analysis, governance, and audit information. The document includes comprehensive financial figures for the full fiscal year 2025, management's discussion of business segments, industry conditions, and future outlook. It also references the audit report by an accounting firm and includes signatures from company officers guaranteeing the accuracy of the report. The length of the document (15,000 characters) and the depth of content confirm it is the full annual report rather than an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2025
2026-03-09 Chinese
2025年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2025 年年度报告摘要" which translates to "2025 Annual Report Summary". It contains detailed financial data for the year 2025, including total assets, net profit, revenue, and quarterly financial data. It also discusses company business activities, shareholder information, major events during the year such as control changes, asset sales, and management changes. The document is over 6,000 characters, indicating it is a substantive report rather than a brief announcement. The content aligns with the characteristics of an Annual Report (10-K) as it covers comprehensive company activity and full financial performance for the fiscal year 2025. Therefore, the correct classification is Annual Report (10-K). FY 2025
2026-03-09 Chinese
内部控制审计报告
Regulatory Filings
2026-03-09 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.